Ian [for Kristen Kluska]'s questions to Supernus Pharmaceuticals Inc (SUPN) leadership • Q1 2025
Question
An analyst named Ian, on for Kristen Kluska of Cantor Fitzgerald, asked about the proportion of Qelbree prescriptions for treatment-naive patients versus those switching from other medications. He also asked for an update on the percentage of adult Qelbree use that is in combination with other therapies.
Answer
Executive Jack Khattar responded that approximately 32-33% of Qelbree patients are naive to ADHD treatment. The remaining 67-68% are switching from other medications, primarily stimulants. He also confirmed that combination use within the adult population remains stable at around 35% to 40% of prescriptions.